Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients (original) (raw)

References

  1. Hunter, M. I. S., Lao, M. S., Burtles, S. S., andDavidson, D. L. W. 1984. Erythrocyte antioxidant enzymes in multiple sclerosis and the effect of hyperbaric oxygen. Neurochem. Res. 9:507–516.
    Article PubMed Google Scholar
  2. Kurantsin-Mills, J., Samji, N., Moscarello, M. A., andBoggs, J. M. 1982. Comparison of membrane structure, osmotic fraglity and morphology of multiple sclerosis and normal erythrocytes. Neurochem. Res. 7:1523–1540.
    Article PubMed Google Scholar
  3. Caspary, E. A., Sewell, F., andField, E. J. 1967. Red blood cell fragility in multiple sclerosis. Brit. Med. J. 2:610–611.
    PubMed Google Scholar
  4. Schauf, C. L., Frischer, H., andDavis, F. A. 1980. Mechanical fragility of erythrocytes in multiple sclerosis. Neurology 30:323–325.
    PubMed Google Scholar
  5. Shukla, V. K. S., Jensen, G. E., andClausen, J. 1977. Erythrocyte glutathione peroxidase deficiency in multiple sclerosis. Acta Neurol. Scand. 56:542–550.
    PubMed Google Scholar
  6. Szeinberg, A., Golan, R., Ezzer, J. B., Sarova-Pinhas, I., andKindler, D. 1981. Decreased erythrocyte glutathione peroxidase activity in multiple sclerosis. Acta Neurol. Scand. 60:265–271.
    Google Scholar
  7. Szeinberg, A., Golan, R., Ben-Ezzer, J., Sarova-Pinhas, I., andKindler, D. 1981. Glutathione peroxidase activity in various types of blood cell in multiple sclerosis. Acta Neurol. Scand. 63:67–75.
    PubMed Google Scholar
  8. Jensen, G. E., Gissel-Neilsen, G., andClausen, J. 1980. Leukocyte glutathione peroxidase E.C.1.11.1.9 activity and selenium level in multiple sclerosis. J. Neurol. Sci. 48:61–68.
    Article PubMed Google Scholar
  9. Jensen, G. E., andClausen, J. 1984. Glutathione peroxidase and reductase, glucose-6-phosphate dehydrogenase and catalase activities in multiple sclerosis. J. Neurol. Sci. 63:45–53.
    Article PubMed Google Scholar
  10. Zachara, B., Gromadzinska, J., Czernicki, J., Maciejek, Z., andChmielewski, H. 1984. Red blood cell glutathione peroxidase activity in multiple sclerosis. Klin. Wochenschr. 62:179–182.
    PubMed Google Scholar
  11. Polidoro, G., Di Ilio, C., Arduini, A., La Rovere, G., andFederici, G. 1984. Superoxide dismutase, reduced glutathione and thiobarbituric acid-reactive products in erythrocytes of patients with multiple sclerosis. Int. J. Biochem. 16:505–509.
    Article PubMed Google Scholar
  12. Rogovina, N. I., andKoklov, A. P. 1980. Metabolism of lipid peroxidation products in multiple sclerosis patients. Zh. Nevropatol. Paikhiatr. Im. S. S. Korsakova 80:696–700.
    Google Scholar
  13. Yu, R. K., Ueno, K., Glaser, G. H., andTourtellotte, W. W. 1982. Lipid and protein alterations of spinal cord and cord myelin of multiple sclerosis. J. Neurochem. 39:464–477.
    PubMed Google Scholar
  14. Woelk, H., andBorri, P. 1973. Lipid and fatty acid composition of myelin purified from normal and MS brains. Eur. Neurol. 10:250–260.
    PubMed Google Scholar
  15. Gopfert, E., Pytlik, S., andDebuch, H. 1980. 2′,3′-Cyclic nucelotide 3′-phosphohydrolase and lipids of myelin from multiple sclerosis and normal brains. J. Neurochem. 34:732–739.
    PubMed Google Scholar
  16. Thompson, R. H. S. 1975. Unsaturated fatty acids in multiple sclerosis. Pages 184–191.In Davison, A. N., Humphrey, J. H., Liversedge, L. A., McDonald, W. I., andPorterfield, J. S. (eds). Multiple sclerosis research. HMSO: London.
    Google Scholar
  17. Baker, R. W. R., Thompson, R. H. S., andZilkha, K. J. 1964. Serum fatty acids and multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 27:408–414.
    PubMed Google Scholar
  18. Sanders, H., Thompson, R. H. S., Wright, H. P., andZilkha, K. J. 1968. Further studies on platelet adhesion and serum cholesteryl linoleate levels in multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 31:321–325.
    PubMed Google Scholar
  19. Neu, I. S. 1983. Essential fatty acids in the serum and cerebrospinal fluid of multiple sclerosis patients. Acta Neurol. Scand. 67:151–163.
    PubMed Google Scholar
  20. Gul, S., Smith, A. D., Thompson, R. H. S., Wright, H. P., andZilkha, K. J. 1970. Fatty acid composition of phospholipids from platelets and erythrocytes in multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 33:506–510.
    PubMed Google Scholar
  21. Cherayil, G. D. 1984. Sialic acid and fatty acid concentrations in lymphocytes, red blood cells and plasma from patients with multiple sclerosis. J. Neurol. Sci. 63:1–10.
    Article PubMed Google Scholar
  22. Bernsohn, J., andStephanides, L. M. 1967. Aetiology of multiple sclerosis. Nature 215:821–823.
    PubMed Google Scholar
  23. Dick, G. 1976. The aetiology of multiple sclerosis. Proc. Roy. Soc. Med. 69:611–615.
    PubMed Google Scholar
  24. Jones, R., Preece, A. W., Luckman, N. P., andForrester, J. A. 1983. The analysis of the red blood cell unsaturated fatty acid test for multiple sclerosis using laser cytopherometry. Phys. Med. Biol. 28:1145–1151.
    Article PubMed Google Scholar
  25. Mertin, J., andMeade, C. J. 1977. Relevance of fatty acids in multiple sclerosis. Brit. Med. Bull. 33:67–71.
    PubMed Google Scholar
  26. Wickstrom, J., Westermark, T., andPalo, J. 1976. Selenium, vitamin E and copper in multiple sclerosis. Acta Neurol. Scand. 54:287–290.
    PubMed Google Scholar
  27. Fletcher, B. L., Dillard, C. J., andTappel, A. L. 1973. Measurement of fluorescent lipid peroxidation products in biological systems and tissues. Anal. Biochem. 52:1–9.
    Article PubMed Google Scholar
  28. Al-Timimi, D. J., andDormandy, T. L. 1977. The inhibition of lipid autoxidation by human caeruloplasmin. Biochem. J. 168:283–288.
    PubMed Google Scholar
  29. Satoh, K. 1978. Serum lipid peroxide in cerebrovascular disorders detected by a new colorimetric method. Clin. Chim. Acta. 90:37–43.
    Article PubMed Google Scholar
  30. Stocks, J., andDormandy, T. L. 1971. The autoxidation of human red cell lipids induced by hydrogen peroxide. Brit. J. Haematol. 20:95–111.
    Google Scholar
  31. Dillard, C. J., andTappel, A. L. 1971. Fluorescent products of lipid peroxidation of mitochondria and microsomes. Lipids 6:715–721.
    PubMed Google Scholar
  32. Beynon, R. J. 1983. In: Contributed Programs Vol. 1, Biochemistry Microcomputer Group, University of Liverpool.
  33. Halliwell, B., andGutteridge, J. M. C. 1984. Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet (i):1396–1397.
    Article Google Scholar
  34. Slater, T. F. 1984. Free-radical mechanisms in tissue injury. Biochem. J. 222:1–15.
    PubMed Google Scholar
  35. Gutteridge, J. M. C., andStocks, J. 1981. Caeruloplasmin: physiological and pathological perspectives. CRC Crit. Rev. Clin. Lab. Sci. 14:257–329.
    Google Scholar
  36. Gutteridge, J. M. C., Richmond, R., andHalliwell, B. 1980. Oxygen free radicals and lipid peroxidation. Inhibition by the protein caeruloplasmin. FEBS Lett. 112:269–272.
    Article Google Scholar
  37. Bowern, N., Ramshaw, I. A., Clark, I. A., andDoherty, P. C. 1984. Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J. Exp. Med. 160:1532–1543.
    Article PubMed Google Scholar

Download references